Stock Research for SLP

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

SLP Stock Chart & Research Data

The SLP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SLP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


SLP Due diligence Resources & Stock Charts

The SLP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SLP Detailed Price Forecast - CNN Money CNN View SLP Detailed Summary - Google Finance
Yahoo View SLP Detailed Summary - Yahoo! Finance Zacks View SLP Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View SLP Trends & Analysis - Trade-Ideas Barrons View SLP Major Holders - Barrons
NASDAQ View SLP Call Transcripts - NASDAQ Seeking View SLP Breaking News & Analysis - Seeking Alpha
Spotlight View SLP Annual Report - CompanySpotlight.com OTC Report View SLP OTC Short Report - OTCShortReport.com
TradeKing View SLP Fundamentals - TradeKing Charts View SLP SEC Filings - Bar Chart
WSJ View Historical Prices for SLP - The WSJ Morningstar View Performance/Total Return for SLP - Morningstar
MarketWatch View the Analyst Estimates for SLP - MarketWatch CNBC View the Earnings History for SLP - CNBC
StockMarketWatch View the SLP Earnings - StockMarketWatch MacroAxis View SLP Buy or Sell Recommendations - MacroAxis
Bullish View the SLP Bullish Patterns - American Bulls Short Pains View SLP Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View SLP Stock Mentions - StockTwits PennyStocks View SLP Stock Mentions - PennyStockTweets
Twitter View SLP Stock Mentions - Twitter Invest Hub View SLP Investment Forum News - Investor Hub
Yahoo View SLP Stock Mentions - Yahoo! Message Board Seeking Alpha View SLP Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for SLP - SECform4.com Insider Cow View Insider Transactions for SLP - Insider Cow
CNBC View SLP Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SLP - OTC Markets
Yahoo View Insider Transactions for SLP - Yahoo! Finance NASDAQ View Institutional Holdings for SLP - NASDAQ


Stock Charts

FinViz View SLP Stock Insight & Charts - FinViz.com StockCharts View SLP Investment Charts - StockCharts.com
BarChart View SLP Stock Overview & Charts - BarChart Trading View View SLP User Generated Charts - Trading View




Latest Financial News for SLP


Is Simulations Plus Inc’s (NASDAQ:SLP) PE Ratio A Signal To Buy For Investors?
Posted on Wednesday October 10, 2018

This analysis is intended to introduce important early concepts to people who are starting to invest and want to start learning about core concepts of fundamental analysis on practical examples


How Simulations Plus Inc (NASDAQ:SLP) Delivered A Better ROE Than Its Industry
Posted on Friday September 14, 2018

I am writing today to help inform people who are new to the stock market and want to learn about Return on Equity using a real-life example. Simulations Plus IncRead More...


Simulations Plus Receives New Grant Award from the FDA
Posted on Wednesday September 12, 2018

Simulations Plus, Inc. (SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that it has received notice from the U.S. Food and Drug Administration (FDA) that it has been awarded a new funded cooperative agreement, for $250,000 per year for up to two years, to integrate drug product quality attributes into the mechanistic Transdermal Compartmental Absorption and Transit (TCAT™) model in GastroPlus™.


Simulations Plus Extends Funded Research Collaboration with the FDA
Posted on Wednesday September 05, 2018

Simulations Plus, Inc. (SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that it has entered into a one-year funded extension to its previous cooperative agreement (grant 1U01FD005211) with the U.S. Food and Drug Administration (FDA) to further develop and validate the mechanistic Ocular Compartmental Absorption and Transit (OCAT™) model in GastroPlus™.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.